Bexson Biomedical Wearable Ketamine Device to be Tested During U.S. Military Training Exercise in August webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases , today announced it has entered into. | June 21, 2023
WATERTOWN, Mass., June 20, 2023 C4 Therapeutics, Inc. , a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of. | June 20, 2023
POSITIVE RECOMMENDATION BY COMMITTEE FOR ADVANCED THERAPIES CONFIRMS QUALITY OF THE MANUFACTURING PROCESS AND PRECLINICAL DATA SUBMITTED Mendus AB , a biopharmaceutical company focused on. | June 19, 2023
SAN DIEGO, June 16, 2023 /PRNewswire/ Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its. | June 16, 2023
Paris , 21 October 2021 - Ipsen , a global specialty-driven biopharmaceutical group, publishes its sales performance for the third quarter of 2021 and the year to date.
PARIS, France, June 14th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | June 14, 2023
WILMETTE, Ill., June 14, 2023 Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that. | June 14, 2023
WEXFORD, Pa., June 14, 2023 /PRNewswire/ Coeptis Therapeutics Holdings, Inc. , a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced the pricing of. | June 14, 2023
Almirall S.A. , a global biopharmaceutical company focused on skin health, has announced today the pricing and closing of its EUR 200,000,000 non-pre-emptive share capital increase announced. | June 13, 2023